Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2019-01-02$0.00/sh+125,000$125→ 125,000 totalExercise: $0.38Exp: 2029-01-02→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]41,667 options will be exercisable on or after 1/2/2019; 41,667 options will be exercisable on or after 7/2/2019; and 41,666 options will be exercisable on or after 1/2/2020.